Whole-body diffusion-weighted mri: Tips, tricks, and pitfalls

American Journal of Roentgenology

Volumn 199, Issue 2, 2012, Pages 252-262

  Koh, Dow Mu ^a   Blackledge, Matthew ^b   Padhani, Anwar R ^c   Takahara, Taro ^d   Kwee, Thomas C ^e   Leach, Martin O ^b   Collins, David J ^b  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c Paul Strickland Scanner Centre   (United Kingdom)

^d TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Diffusion weighted imaging; MRI; Oncology; Pitfalls; Technique; Whole body

Indexed keywords

ANTINEOPLASTIC AGENT; BORTEZOMIB; CYCLOPHOSPHAMIDE; DEXAMETHASONE; FLUORODEOXYGLUCOSE F 18; GRANULOCYTE COLONY STIMULATING FACTOR; TECHNETIUM 99M; THALIDOMIDE;

APPARENT DIFFUSION COEFFICIENT; ARTIFACT REDUCTION; BONE METASTASIS; BONE SCINTISCANNING; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; ECHO PLANAR IMAGING; FALSE POSITIVE RESULT; HUMAN; IMAGE PROCESSING; IMAGE QUALITY; LUNG CANCER; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MELANOMA; MULTIPLE MYELOMA; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; TREATMENT RESPONSE; TRIPLE NEGATIVE BREAST CANCER; WHOLE BODY DIFFUSION WEIGHTED IMAGING; WHOLE BODY MRI;

ARTIFACTS; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; NEOPLASMS; WHOLE BODY IMAGING;

EID: 84864739157     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.11.7866     Document Type: Review

References (60)

1. Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR 2007; 188:1622-1635 (Pubitemid 46866868)
2. Thoeny HC, De Keyzer F. Extracranial applications of diffusion-weighted magnetic resonance imaging. Eur Radiol 2007; 17:1385-1393 (Pubitemid 46767586)
3. Padhani AR, Liu G, Koh DM, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009; 11:102-125
4. Koh DM, Takahara T, Imai Y, Collins DJ. Practical aspects of assessing tumors using clinical diffusion- weighted imaging in the body. Magn Reson Med Sci 2008; 6:211-224
5. Takahara T, Imai Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 2004; 22:275-282 (Pubitemid 39264807)
6. Steinborn MM, Heuck AF, Tiling R, Bruegel M, Gauger L, Reiser MF. Whole-body bone marrow MRI in patients with metastatic disease to the skeletal system. J Comput Assist Tomogr 1999; 23:123-129 (Pubitemid 29095482)
7. Eustace S, Tello R, DeCarvalho V, Carey J, Melhem E, Yucel EK. Whole body turbo STIR MRI in unknown primary tumor detection. J Magn Reson Imaging 1998; 8:751-753 (Pubitemid 28267802)
8. Lauenstein TC, Freudenberg LS, Goehde SC, et al. Whole-body MRI using a rolling table platform for the detection of bone metastases. Eur Radiol 2002; 12:2091-2099 (Pubitemid 36940299)
9. Ghanem N, Lohrmann C, Engelhardt M, et al. Whole-body MRI in the detection of bone marrow infiltration in patients with plasma cell neoplasms in comparison to the radiological skeletal survey. Eur Radiol 2006; 16:1005-1014
10. Herborn CU, Unkel C, Vogt FM, Massing S, Lauenstein TC, Neumann A. Whole-body MRI for staging patients with head and neck squamous cell carcinoma. Acta Otolaryngol 2005; 125:1224-1229 (Pubitemid 41800877)
11. Brennan DD, Gleeson T, Coate LE, Cronin C, Carney D, Eustace SJ. A comparison of wholebody MRI and CT for the staging of lymphoma. AJR 2005; 185:711-716
12. Engelhard K, Hollenbach HP, Wohlfart K, von Imhoff E, Fellner FA. Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening for bone metastases in patients with breast cancer. Eur Radiol 2004; 14:99-105 (Pubitemid 38181060)
13. Kruger DG, Riederer SJ, Grimm RC, Rossman PJ. Continuously moving table data acquisition method for long FOV contrast-enhanced MRA and wholebody MRI. Magn Reson Med 2002; 47:224-231 (Pubitemid 34116789)
14. Schmidt GP, Reiser MF, Baur-Melnyk A. Wholebody MRI for the staging and follow-up of patients with metastasis. Eur J Radiol 2009; 70:393-400
15. Börnert P, Aldefeld B. Principles of whole-body continuously-moving- table MRI. J Magn Reson Imaging 2008; 28:1-12 (Pubitemid 351956459)
16. Han Y, Weigel M, Huff S, Ludwig U. Whole-body diffusion-weighted imaging with a continuously moving table acquisition method: preliminary results. Magn Reson Med 2011;
17. Bammer R. Basic principles of diffusion-weighted imaging. Eur J Radiol 2003; 45:169-184 (Pubitemid 36197713)
18. Patterson DM, Padhani AR, Collins DJ. Technology insight: water diffusion MRI-a potential new biomarker of response to cancer therapy. Nat Clin Pract Oncol 2008; 5:220-233 (Pubitemid 351493681)
19. Smith-Bindman R. Is computed tomography safe? N Engl J Med 2010; 363:1-4
20. Redberg RF. Cancer risks and radiation exposure from computed tomographic scans: how can we be sure that the benefits outweigh the risks? Arch Intern Med 2009; 169:2049-2050
21. Krohmer S, Sorge I, Krausse A, et al. Whole-body MRI for primary evaluation of malignant disease in children. Eur J Radiol 2010; 74:256-261
22. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45:228-247
23. Costelloe CM, Chuang HH, Madewell JE, Ueno NT. Cancer response criteria and bone metastases: RECIST 1.1, MDA and PERCIST. J Cancer 2010; 1:80-92
24. Krüger S, Buck AK, Mottaghy FM, et al. Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18Ffluoride PET or 18F-FDG PET/CT. Eur J Nucl Med Mol Imaging 2009; 36:1807-1812
25. Ak I, Sivrikoz MC, Entok E, Vardareli E. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography. Eur J Cardiothorac Surg 2010; 37:792-796
26. Gould P. Medical isotope shortage reaches crisis level. Nature 2009; 460:312-313
27. Chan Y, Chan K, Lam W, Metreweli C. Comparison of whole body MRI and radioisotope bone scintigram for skeletal metastases detection. Chin Med J (Engl) 1997; 110:485-489 (Pubitemid 127510175)
28. Imamura F, Kuriyama K, Seto T, et al. Detection of bone marrow metastases of small cell lung cancer with magnetic resonance imaging: early diagnosis before destruction of osseous structure and implications for staging. Lung Cancer 2000; 27:189-197 (Pubitemid 30105658)
29. Mentzel HJ, Kentouche K, Sauner D, et al. Comparison of whole-body STIR-MRI and 99mTcmethylene- diphosphonate scintigraphy in children with suspected multifocal bone lesions. Eur Radiol 2004; 14:2297-2302 (Pubitemid 40057942)
30. Nakanishi K, Kobayashi M, Takahashi S, et al. Whole body MRI for detecting metastatic bone tumor: comparison with bone scintigrams. Magn Reson Med Sci 2005; 4:11-17
31. Sohaib SA, Cook G, Allen SD, Hughes M, Eisen T, Gore M. Comparison of whole-body MRI and bone scintigraphy in the detection of bone metastases in renal cancer. Br J Radiol 2009; 82:632-639
32. Balliu E, Boada M, Pelaez I, et al. Comparative study of whole-body MRI and bone scintigraphy for the detection of bone metastases. Clin Radiol 2010; 65:989-996
33. Darge K, Jaramillo D, Siegel MJ. Whole-body MRI in children: current status and future applications. Eur J Radiol 2008; 68:289-298
34. Ladd SC. Whole-body MRI as a screening tool? Eur J Radiol 2009; 70:452-462
35. Lenz C, Klarhofer M, Scheffler K, Winter L, Sommer G. Assessing extracranial tumors using diffusion-weighted whole-body MRI. Z Med Phys 2011; 21:79-90
36. 18F-FDG PET/CT. AJR 2011; 196:662-669
37. Sommer G, Klarhofer M, Lenz C, Scheffler K, Bongartz G, Winter L. Signal characteristics of focal bone marrow lesions in patients with multiple myeloma using whole body T1w-TSE, T2w- STIR and diffusion-weighted imaging with background suppression. Eur Radiol 2011; 21:857-862
38. Lin C, Itti E, Luciani A, et al. Whole-body diffusion- weighted imaging with apparent diffusion coefficient mapping for treatment response assessment in patients with diffuse large B-cell lymphoma: pilot study. Invest Radiol 2011; 46:341-349
39. Lin C, Luciani A, Itti E, et al. Whole-body diffusion- weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma. Eur Radiol 2010; 20:2027-2038
40. Laurent V, Trausch G, Bruot O, Olivier P, Felblinger J, Regent D. Comparative study of two whole-body imaging techniques in the case of melanoma metastases: advantages of multi-contrast MRI examination including a diffusionweighted sequence in comparison with PET-CT. Eur J Radiol 2010; 75:376-383
41. Kwee TC, Takahara T, Vermoolen MA, Bierings MB, Mali WP, Nievelstein RA. Whole-body diffusion-weighted imaging for staging malignant lymphoma in children. Pediatr Radiol 2010; 40:1592-1602
42. Kwee TC, Fijnheer R, Ludwig I, et al. Wholebody magnetic resonance imaging, including diffusion- weighted imaging, for diagnosing bone marrow involvement in malignant lymphoma. Br J Haematol 2010; 149:628-630
43. Heusner TA, Kuemmel S, Koeninger A, et al. Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging. Eur J Nucl Med Mol Imaging 2010; 37:1077-1086
44. Gutzeit A, Doert A, Froehlich JM, et al. Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma. Skeletal Radiol 2010; 39:333-343
45. Chen YB, Hu CM, Chen GL, Hu D, Liao J. Staging of uterine cervical carcinoma: whole-body diffusion-weighted magnetic resonance imaging. Abdom Imaging 2011; 36:619-626
46. Chen W, Jian W, Li HT, et al. Whole-body diffusion- weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer: how do they measure up? Magn Reson Imaging 2010; 28:613-620
47. Takenaka D, Ohno Y, Matsumoto K, et al. Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion- weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy. J Magn Reson Imaging 2009; 30:298-308
48. Stecco A, Romano G, Negru M, et al. Wholebody diffusion-weighted magnetic resonance imaging in the staging of oncological patients: comparison with positron emission tomography computed tomography (PET-CT) in a pilot study. Radiol Med (Torino) 2009; 114:1-17
49. Kwee TC, van Ufford HM, Beek FJ, et al. Wholebody MRI, including diffusion-weighted imaging, for the initial staging of malignant lymphoma: comparison to computed tomography. Invest Radiol 2009; 44:683-690
50. Ohno Y, Koyama H, Onishi Y, et al. Non-small cell lung cancer: whole-body MR examination for M-stage assessment - utility for whole-body diffusion- weighted imaging compared with integrated FDG PET/CT. Radiology 2008; 248:643-654
51. Guan YJ, Ling HW, Chen KM. Preliminary application of whole body diffusion weighted imaging in screening metastasis. Chin Med Sci J 2008; 23:178-182
52. Nakanishi K, Kobayashi M, Nakaguchi K, et al. Whole-body MRI for detecting metastatic bone tumor: diagnostic value of diffusion-weighted images. Magn Reson Med Sci 2007; 6:147-155
53. Schick F. Whole-body MRI at high field: technical limits and clinical potential. Eur Radiol 2005; 15:946-959 (Pubitemid 41166727)
54. Merkle EM, Dale BM, Paulson EK. Abdominal MR imaging at 3T. Magn Reson Imaging Clin N Am 2006; 14:17-26 (Pubitemid 43363395)
55. Takahara T, Kwee T, Kibune S, et al. Whole-body MRI using a sliding table and repositioning surface coil approach. Eur Radiol 2010; 20:1366-1373
56. Ma J, Costelloe CM, Madewell JE, et al. Fast Dixon-based multisequence and multiplanar MRI for whole-body detection of cancer metastases. J Magn Reson Imaging 2009; 29:1154-1162
57. Nagy Z, Weiskopf N. Efficient fat suppression by slice-selection gradient reversal in twice-refocused diffusion encoding. Magn Reson Med 2008; 60:1256-1260
58. Li S, Sun F, Jin ZY, Xue HD, Li ML. Whole-body diffusion-weighted imaging: technical improvement and preliminary results. J Magn Reson Imaging 2007; 26:1139-1144 (Pubitemid 47548180)
59. Dorenbeck U, Butz B, Schlaier J, Bretschneider T, Schuierer G, Feuerbach S. Diffusion-weighted echo-planar MRI of the brain with calculated ADCs: a useful tool in the differential diagnosis of tumor necrosis from abscess? J Neuroimaging 2003; 13:330-338 (Pubitemid 37159020)
60. Fischer MA, Nanz D, Hany T, et al. Diagnostic accuracy of whole-body MRI/DWI image fusion for detection of malignant tumours: a comparison with PET/CT. Eur Radiol 2011; 21:246-255